利妥昔单抗治疗老年人脾边缘区淋巴瘤二例并文献复习
被引量：4
摘要
目的探讨老年人脾边缘区淋巴瘤（SMZL）的诊断、治疗方法。方法报道2例年龄〉70岁伴有巨脾的SMZL，并对其临床表现、诊断及治疗进行文献复习。结果SMZL多见于老年患者，常表现为脾大，具有与脾功能亢进相似的症状和体征。骨髓流式细胞术结合细胞形态学检查有助于诊断。可行利妥昔单抗单药治疗，疗效较好。结论流式细胞术对SMZL的诊断及治疗均有重要的指导作用。
出处
《白血病．淋巴瘤》
CAS
2011年第4期247-249,共3页
Journal of Leukemia & Lymphoma
参考文献9
-
1Ferreri AJ,Zucca E.Marginal-zone lymphoma.Cirt Rev Oncol Hematol,2007,63:245-246. 被引量：1
-
2Hermine O,Lefrère F,Bronowicki JP,et al.Regression of splenic lymphoma with villous lymphocytes after treatment of hematitis C virus infection.N Engl J Med,2002,347:89-94. 被引量：1
-
3Troussard X,Valersi F,Duchayne E,et al.Splenic lymphoma with villous lymphocytes:clinical presentation,biology and prognostic factors in a series of 100 patient.Br J Haematol,1996,93:731-736. 被引量：1
-
4张之南,沈悌主编..血液病诊断及疗效标准 第3版[M].北京:科学出版社,2007:271.
-
5Mateo M,Mollejo M,Villuendas R,et al.7q31-32allelic loss is a frequent finding in splenic marginal zone lymphoma.Am J Pathol,1999,154:1583-1589. 被引量：1
-
6Algara P,Mateo MS,Sanchez-Beato M,et al.Analysis of the IgV(H)somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course.Blood,2002,99:1299-1304. 被引量：1
-
7Murakami H,Irisawa H,Saitoh T,et al.Immunological abnormalities in splenic marginal zone cell lymphoma.Am J Hematol,1997,56:173-178. 被引量：1
-
8Tsimberidou AM,Catovsky D,Schlette E,et al.Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy lone.Cancer,2006,107:125-135. 被引量：1
-
9Forero A,Lobuglio AF.History of antibody therapy for non-Hodgkin's lymphoma.Semin Oncol,2003,30:1-5. 被引量：1
同被引文献49
-
1达永,张伟京,苏航,陈喜林,仲凯励,余金得,俞受程.利妥昔单抗联合化疗治疗CD_(20)^+的B细胞型非霍奇金淋巴瘤27例[J].白血病．淋巴瘤,2006,15(5):371-372. 被引量：9
-
2Swerdiow SH, Campo E, Harris NL, et al. WHO classification of tumors of haematopoietic and lymphoid tissues.4th ed. Lyon: IARC Press, 2008: 185-188. 被引量：1
-
3Li L, Bierman P, Vose J, et al. High-dose therapy/autologous hematopoietic stem cell transplantation in relapsed or refractory marginal zone non-Hodgkin lymphoma. Clin Lymphoma Myeloma Leuk, 2011, 11:253-256. 被引量：1
-
4Witzig TE, Geyer SM, Kurtin PJ, et al. Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin's lymphoma: a phase II trim in the North Centerl Cancer Treatment Group. Leuk Lymphoma, 2008, 49:1074-1080. 被引量：1
-
5Tsang RW, Gospodarowicz MK, Pintilie M, et al. Localized mucosa- associated lymphoma tissue lymphoma treated with radiation therapy has excellent chinical outcome. J Clin Oncol, 2003, 21: 4157-4164. 被引量：1
-
6Montalban C, Sant6n A, Redondo C, et al. Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with Helicobacter pylori eradication. Lack of association with translocation t (11;18): a 10-year updated follow-up a prospective study. Ann Oncol, 2005, 16: 1539-1544. 被引量：1
-
7Raderer M, Streubel B, WShrer S, et al. High relapse rate in patients with MALT lymphoma warrants life long follow-up. Clin Cancer Res, 2005,11:3349-3352. 被引量：1
-
8Raderer M, Wfihrer S, Streubel B, et al. Assessment of disease dissemination in gastric compared with extragastric mucosa -associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol, 2006, 24: 3136-3141. 被引量：1
-
9Hitchcock S, Ng AK, Fisher DC, Silver B, et al. Treatment outcome of mucosa-associated lymphoid tissue/marginal zone non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys, 2002, 52: 1058-1066. 被引量：1
-
10Arcaini L, Pauli M, Burcheri S, et al. Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease. Br J Haematal, 2007, 136: 301-304. 被引量：1
引证文献4
-
1盂祥睿,王华庆,崔秀珍.大剂量化疗联合自体造血干细胞移植治疗复发、难治性边缘区非霍奇金淋巴瘤疗效观察[J].白血病．淋巴瘤,2012,21(10):595-597. 被引量：2
-
2贺建霞,杨斌,张宏伟,白敏.R-CHOP方案治疗脾边缘区B细胞淋巴瘤一例并文献复习[J].白血病．淋巴瘤,2013,22(5):302-305.
-
3卞恒娟,王会平,陶千山,熊术道,张翠,陶莉莉,潘莹,翟志敏.细针穿刺细胞学联合流式细胞术在B细胞非霍奇金淋巴瘤诊断及分类中的应用[J].白血病．淋巴瘤,2014,23(4):223-227. 被引量：4
-
4楚松林,吴重阳,辛星,张玉生,张连生.伴绒毛状细胞的脾B细胞边缘区淋巴瘤一例并文献复习[J].白血病．淋巴瘤,2014,23(5):304-307.
二级引证文献6
-
1王婷婷,王昭,付丽,魏娜,黄达永,王晶石,沈晶,杨凌志,崔华,熊梅.改良Hyper—CVAD／MA方案治疗侵袭性淋巴瘤42例[J].白血病．淋巴瘤,2014,23(5):284-286. 被引量：1
-
2石远凯,孙燕.中国恶性实体瘤自体造血干细胞移植25年回顾[J].中华医学杂志,2015,95(10):721-726. 被引量：5
-
3唐丽娜,沈友洪,吴周贵,杜忠实.超声引导下粗针穿刺活检在淋巴瘤诊断中的价值[J].中华医学超声杂志（电子版）,2015,12(3):66-68. 被引量：8
-
4许京淑,李松,陈杨杨,徐奔,向航.利妥昔单抗治疗非霍奇金淋巴瘤的远期疗效及其对免疫水平的影响[J].疑难病杂志,2016,15(10):1048-1051. 被引量：10
-
5吕占武,黄志严.流式细胞术联合免疫组织化学在淋巴结粗针活组织检查诊断淋巴瘤中的应用[J].白血病．淋巴瘤,2016,25(11):651-654. 被引量：2
-
6金鑫,田树元,周梦,周雯霏.空芯针穿刺联合流式细胞术用于肿大淋巴结诊断的价值[J].浙江医学,2020,42(13):1427-1429.
-
1赵征,雷宝霞.脾边缘区淋巴瘤诊治和预后研究进展[J].现代肿瘤医学,2011,19(10):2132-2134. 被引量：2
-
2卢锦波,范磊,徐卫,李建勇.脾边缘区淋巴瘤诊断和治疗进展[J].临床血液学杂志,2015,28(6):1002-1005. 被引量：1
-
3吕瑞,易树华,李增军,刘薇,李姮,熊文婕,邱录贵.脾边缘区淋巴瘤91例临床疗效分析[J].中国实验血液学杂志,2015,23(5):1309-1313.
-
4贺建霞,杨斌,张宏伟,白敏.R-CHOP方案治疗脾边缘区B细胞淋巴瘤一例并文献复习[J].白血病．淋巴瘤,2013,22(5):302-305.
-
5王翠芝,冯向东,罗静,史斌.脾边缘区淋巴瘤一例随访16年并文献复习[J].白血病．淋巴瘤,2009,18(3):146-148. 被引量：1
-
6MolinaT,吴强,等.伴或不伴浆细胞分化的脾边缘区淋巴瘤[J].临床与实验病理学杂志,2002,18(1):37-37.
-
7阎禹廷,易树华,邱录贵.脾边缘区淋巴瘤发病机制研究进展[J].中华血液学杂志,2016,37(4):348-352. 被引量：3
-
8何成年,刘晓民,滑红英.巨脾并多发性脾动脉瘤一例[J].中华放射学杂志,2009,43(3):325-325.
-
9杨申淼,江倩,江滨,陈定宝,王婧,江浩,路瑾,卢锡京,鲍立,石红霞,刘艳荣,黄晓军.伴血象异常的脾边缘区淋巴瘤的临床特点[J].中国实验血液学杂志,2013,21(1):87-94. 被引量：15
-
10吴凌,田晨,张翼鷟.脾边缘区淋巴瘤的治疗进展[J].中国实验血液学杂志,2017,25(2):600-603. 被引量：3
